November 2024 Supplement - Endovascular Today
Embracing a New Era: Putting Data Into Practice. Dr. Silver moderates a panel of experts who discuss their experiences with the Neuroguard IEP® System, insights into the data, device design characteristics, and impact on the field.
Xeltis Receives FDA Breakthrough Device Designation for aXess …
November 19, 2024—Xeltis recently announced that the FDA has granted Breakthrough Device designation for the company’s aXess vascular access conduit and that the first patient was enrolled in the aXess staged pivotal trial in the United States.. The aXess device is intended to enable the creation of a new, permanent, living vessel for …
Iliac Vein Stenting: Best Practices for Patient Safety and Successful ...
Appropriate confirmatory diagnostic imaging on an “intent-to-treat” basis prior to stenting is critical. A combination of multiplanar venography and intravascular ultrasound (IVUS) are gold standards for proper stent placement to identify the degree of stenosis and length of disease.
2024 Archive - Endovascular Today
Microembolization and Carotid Stenting: A Closer Look. Perspectives on the effects of microembolization, protection strategies, recent clinical trial findings, and why carotid stenting should be part of a vascular specialist’s armamentarium.
November 2024 Issue - Endovascular Today
Initiatives to Improve Awareness of Aortic Dissection. Advocates with Aortic Hope/Think Aorta, The John Ritter Foundation for Aortic Health, and The Aortic Dissection Collaborative for Patient-Centered Research discuss how they are raising awareness of aortic …
November 2024 Supplement - Endovascular Today
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Endovascular Today
Biotronik’s BIO-OSCAR FIRST Trial Begins Enrollment. December 19, 2024—Biotronik announced the enrollment of the first patients in its BIO-OSCAR FIRST trial, which is designed to confirm the safety and clinical performance of the company’s Oscar peripheral multifunctional catheter for dilation of lesions in the femoral, popliteal, and …
Synchron’s Brain-Computer Interface Evaluated in COMMAND …
October 3, 2024—Synchron recently announced positive results from the COMMAND early feasibility study, which is evaluating the safety and efficacy of the Synchron brain computer interface (BCI, called the Stentrode) in six patients over a 12-month period.. The results were presented by the COMMAND study Coprincipal Investigator Elad Levy, MD, at the 2024 Congress of Neurological Surgeons ...
1-Year Data Presented From enVVeno’s VenoValve Pivotal Trial
November 20, 2024—enVVeno Medical Corporation announced 1-year data on all patients from SAVVE, the United States pivotal trial of the company’s VenoValve, a surgical replacement venous valve being developed for the treatment of deep venous chronic venous insufficiency (CVI).. The findings were presented at the 51st annual VEITHsymposium held November 19-23, 2024, in New York, New York.
CT Venography: Technique and Indications - Endovascular Today
• Malignancy/limb swelling/lymphedema. Indirect CTV is a general catch-all scan and usually is obviously abnormal or entirely normal. For example, in malignancy, there may be a large lymph node mass clearly causing venous obstruction, or in lymphedema, the scan looks absolutely normal ().• Chronic iliofemoral venous obstruction (cases in which there is a swollen leg).